BioCryst Pharmaceuticals (MEX:BCRX) Total Equity : MXN-9,926 Mil (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is BioCryst Pharmaceuticals Total Equity?

BioCryst Pharmaceuticals's total equity for the quarter that ended in Dec. 2024 was MXN-9,926 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

BioCryst Pharmaceuticals Total Equity Historical Data

The historical data trend for BioCryst Pharmaceuticals's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioCryst Pharmaceuticals Total Equity Chart

BioCryst Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Equity

Get a 7-Day Free Trial

-383.16

-2,194.71

-5,743.46

-7,732.25

-9,925.94

BioCryst Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Equity	Get a 7-Day Free Trial															-7,732.25	-7,902.59	-8,713.15	-9,226.15	-9,925.94

BioCryst Pharmaceuticals Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

BioCryst Pharmaceuticals's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2024 )	-	Total Liabilities(Q: Dec. 2024 )
	=	10228.052	-	20153.989
	=	-9,926

BioCryst Pharmaceuticals's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2024 )	-	Total Liabilities(Q: Dec. 2024 )
	=	10228.052	-	20153.989
	=	-9,926

BioCryst Pharmaceuticals Total Equity Related Terms

Thank you for viewing the detailed overview of BioCryst Pharmaceuticals's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

BioCryst Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioCryst Pharmaceuticals Inc (MEX:BCRX) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

BCRX:USA BO1:Germany

Address

4505 Emperor Boulevard, Suite 200, Durham, NC, USA, 27703

Website

https://www.biocryst.com

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.